Unintended pregnancies with the etonogestrel implant (Implanon): A case series from postmarketing experience in Australia

Contraception

Volumn 71, Issue 4, 2005, Pages 306-308

  Harrison Woolrych, Mira ^a   Hill, Richard ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b THERAPEUTIC GOODS ADMINISTRATION   (Australia)

Author keywords

Contraceptive failure; Etonogestrel implant; Implanon; Unintended pregnancy

Indexed keywords

CYTOCHROME P450 3A4; ETONOGESTREL;

ARTICLE; AUSTRALIA; CONTRACEPTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE; DRUG ANTAGONISM; DRUG EXPOSURE; DRUG MARKETING; EXPERIENCE; FEMALE; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; ORGANIZATION; PATIENT SELECTION; POPULATION RESEARCH; PRACTICE GUIDELINE; PREGNANCY; PUERPERIUM; TECHNIQUE; TRAINING; TREATMENT FAILURE;

EID: 15744396784     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2004.10.005     Document Type: Article

References (4)

1. Implanon Implant. Australian Approved Product Information. March 2003.
2. H.B. Croxatto, and L. Makarainen The pharmacodynamics and efficacy of Implanon Contraception 58 1998 91S 97S
3. L. Mascarenhas Insertion and removal of Implanon Contraception 58 1998 79S 83S
4. B.C.A. Wenck, and P.J. Johnston Implanon and medical indemnity: a case study of risk management using the Australian standard Med. J. Aust. 181 2004 117 119